High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

Einat Shmueli(Hadassah Medical Center), Dana G. Wolf(Hebrew University of Jerusalem), Michal Shapira(University of California, Berkeley), Reuven Or(Hebrew University of Jerusalem), Tali Bdolah‐Abram(Hebrew University of Jerusalem), Orit Caplan, Igor Resnick(Hebrew University of Jerusalem)

The Journal of Infectious Diseases

August 27, 2013

10.1093/infdis/jit475

Cited by 119

Related Papers

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.9k

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

|Blood|1998|1.8k

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

|New England Journal of Medicine|2020|859

Host Immune System Gene Targeting by a Viral miRNA

|Science|2007|642

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

|Journal of Clinical Oncology|2013|439